Oraphine® Soft Capsules

Oraphine® Soft Capsules
Product Description

Relieve moderate to severe acute pain (Nalbuphine HCl 60mg). PhytoHealth at CPHI-Milan 2024. Contact us: [email protected].
- First oral nalbuphine formulation
- Patented technology to improve oral bioavailability
- Fast onset within 15~30 mins
- Ceiling effect of respiratory depression
- Low AEs (vs injection form nalbuphine) and low addiction
- Non-controlled substance in the US and EU 

PhytoHealth Corporation

  • TW
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Out-licensing specialist
Specifications
  • Selling Points
    - First oral nalbuphine formulation
    - Patented technology to improve oral bioavailability
    - Fast onset within 15~30 mins
    - Ceiling effect of respiratory depression
    - Low AEs (vs injection form nalbuphine) and low addiction
    - Non-controlled substance in the US and EU 

PhytoHealth Corporation

  • TW
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Out-licensing specialist

More Products from PhytoHealth Corporation (1)

  • PG2® Lyo. Injection

    Product PG2® Lyo. Injection

    Cancer-related fatigue (CRF) treatment (Astragalus polysaccharides injection 500 mg). PhytoHealth at CPHI-Milan 2024. Contact us: [email protected].

    -The first medicine approved for cancer-related fatigue treatment
    -Compliance with global standards of botanical med...

PhytoHealth Corporation resources (1)